Wordt geladen...
Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies
Lung cancer is the leading cause of cancer-related deaths worldwide. Immune checkpoint inhibitors, including monoclonal antibodies against programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1), have dramatically improved the survival and quality of life of a subset of non-small cell lung c...
Bewaard in:
| Gepubliceerd in: | Front Oncol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8185359/ https://ncbi.nlm.nih.gov/pubmed/34113560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.635007 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|